New Therapies and What Comes Next

About this episode

Lisa Salberg and Dr. Marty Maron discuss the latest developments in HCM treatments and their implications for patients.

Lisa Salberg and Dr. Marty Maron break down the latest HCM developments from ACC, including emerging myosin inhibitors, AI in imaging, and new approaches to fibrosis and genetic therapies. They also explain what these advances mean for patients now and how to prepare for a rapidly evolving treatment landscape. This conversation was record April 10, 2026

People in this episode

Host: Lisa Salberg

Guest: Dr. Marty Maron

Topics covered

• HCM developments
• myosin inhibitors
• AI in imaging
• fibrosis therapies
• genetic therapies
• patient care
• treatment landscape

Keywords

• HCM
• myosin inhibitors
• AI
• fibrosis
• genetic therapies
• treatment advances
• patient care

Mentioned in this episode

Organizations: ACC

Products: myosin inhibitors, AI in imaging, fibrosis and genetic therapies

More episodes of Tales from the Heart

• Surgery, Science and HCM Success · June 8, 2026 · 1h 3m
• MRI Insights and HCM Risk · June 8, 2026 · 41 min
• India’s Growing HCM Awareness Movement · May 11, 2026 · 41 min
• SPECIAL REPORT: A Breakthrough for Non Obstructive HCM · May 6, 2026 · 58 min
• HCM Treatment Shifts and New Therapies · May 5, 2026 · 48 min
• Atrial Fibrillation Risk and New HCM Therapies · May 5, 2026 · 30 min